Shareholding disclosure

Nxera Pharma Co., Ltd

Declared position

Threshold

Fell below threshold

Timeline

Published

14.05.2026

Transaction

08.05.2026

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000S2P3

Beneficial owner

Nxera Pharma Co., Ltd

Declared address

Nxera Pharma Co., Ltd., Tokyo, JP

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Nxera Pharma Co., Ltd

Santhera Pharmaceuticals Holding AG14.05.2026ZA01-000000000S2P3

Disclosure summary

Nxera Pharma Co., Ltd disclosed a holding in Santhera Pharmaceuticals Holding AG that fell below the publication threshold, published by SIX Exchange Regulation on 14.05.2026, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Nxera Pharma Co., Ltd disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 14.05.2026.

Publication date14.05.2026

Transaction date08.05.2026

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerNxera Pharma Co., Ltd

Declared addressNxera Pharma Co., Ltd., Tokyo, JP

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDZA01-000000000S2P3

Source: SIX Exchange Regulation · Publication date: 14.05.2026

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open